Travere Therapeutics, Inc. (NASDAQ:TVTX) stock fell Tuesday as the company faces significant selling pressure following a corporate update that raised concerns among investors. The stock’s decline comes as the broader market is experiencing mixed performance, with the S&P 500 down 0.16% and the…
Continue reading...